Erytech Pharma S.A. (NASDAQ:ERYP) is set to announce third quarter earning results on Thursday 5th November 2020, after market close.
Stock Performance
Shares of Erytech Pharma S.A. traded up $ 0.81 or 13.30 percent on Wednesday, reaching $ 6.90 with volume of 7.20 thousand shares. Erytech Pharma S.A. has traded high as $ 6.90 and has cracked $ 6.30 on the downward trend
The closing price of $ 6.90, representing a 74.00 % increase from the 52 week low of $ 3.50 and a 56.34 % decrease over the 52 week high of $ 13.95.
The company has a market capital of $ 134.14 million and is part of the Healthcare sector and Biotechnology industry.
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for severe forms of cancer and orphan diseases. The companys lead product candidate is eryaspase, which is in Phase III clinical development for the treatment of second-line pancreatic cancer and in Phase II stage for the treatment of triple-negative breast cancer. ERYTECH Pharma S.A.